Latest news, press releases, and SEC filings for Taysha Gene Therapies Inc (TSHA) https://caymanjournal.com/stock/TSHA en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 20:30:15 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 **⚠️ Important Notice:** The provided input only contains the metadata for an SEC filing (`d942601dars.pdf`) but does not include the actual document text or PDF content. Therefore, I cannot summarize the specific details, financials, or commentary. However, as an expert financial analyst, I have p https://caymanjournal.com/stock/TSHA/sec-filing/0001193125-26-168538 https://caymanjournal.com/stock/TSHA/sec-filing/0001193125-26-168538 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing # 📑 What This Document Is ✉️ This document is a Proxy Statement (DEF 14A), which is essentially a mandatory informational packet sent by Taysha Gene Therapies, Inc. to its stockholders. Think of it as the company's formal homework assignment for its annual shareholder meeting. 👉 Why it matters: T https://caymanjournal.com/stock/TSHA/sec-filing/0001193125-26-168525 https://caymanjournal.com/stock/TSHA/sec-filing/0001193125-26-168525 Wed, 22 Apr 2026 00:00:00 GMT SEC Filing